Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,391,548 papers from all fields of science
Search
Sign In
Create Free Account
DU 145
A cell line made from human prostate cancer cells that is used in the laboratory to study the way prostate cancer cells grow.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Casticin inhibits human prostate cancer DU 145 cell migration and invasion via Ras/Akt/NF-κB signaling pathways.
Chia-Chang Lin
,
Kuen-Bao Chen
,
+7 authors
Jing-Gung Chung
Journal of food biochemistry
2019
Corpus ID: 182320409
Casticin, a polymethoxyflavone derived from natural plants, has biological activities including induction of cell apoptosis. In…
Expand
2016
2016
Cytotoxic evaluation of different fractions of Salvia chorassanica Bunge on MCF-7 and DU 145 cell lines
A. Golshan
,
E. Amini
,
+5 authors
Z. Tayarani-Najaran
Research in Pharmaceutical Sciences
2016
Corpus ID: 24306629
Because of antimicrobial, antioxidant, and anticancer potential, Salvia chorassanica Bunge (Lamiaceae) has been considered as a…
Expand
2014
2014
Upregulation of death receptor 5 and activation of caspase 8/3 play a critical role in ergosterol peroxide induced apoptosis in DU 145 prostate cancer cells
Jonghyun Han
,
E. Sohn
,
+8 authors
Sung-Hoon Kim
Cancer Cell International
2014
Corpus ID: 7819603
BackgroundThough ergosterol peroxide (EP) derived from Neungyi mushrooms (Sarcodon aspratus) was known to have cytotoxic…
Expand
2011
2011
The roles of AIF and Endo G in the apoptotic effects of benzyl isothiocyanate on DU 145 human prostate cancer cells via the mitochondrial signaling pathway.
Kuo‐Ching Liu
,
Ya-Ting Huang
,
+6 authors
Jing-Gung Chung
International Journal of Oncology
2011
Corpus ID: 34214978
It is well known that the response of cancer cells to chemotherapeutic drugs involves the activation of apoptotic pathways…
Expand
Highly Cited
2004
Highly Cited
2004
Vesicle traffic through intercellular bridges in DU 145 human prostate cancer cells
C. Vidulescu
,
S. Clejan
,
K. O'Connor
Journal of Cellular and Molecular Medicine
2004
Corpus ID: 25212373
We detected cell‐to‐cell communication via intercellular bridges in DU 145 human prostate cancer cells by fluorescence microscopy…
Expand
Highly Cited
2003
Highly Cited
2003
NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells.
S. Brar
,
Zachary A. Corbin
,
+12 authors
J. Hoidal
American Journal of Physiology - Cell Physiology
2003
Corpus ID: 1814549
Reactive oxygen species (ROS) appear to play an important role in regulating growth and survival of prostate cancer. However, the…
Expand
2001
2001
Comparison of the malignant phenotype and genotype of the human androgen-independent cell line DU 145 and a subline derived from metastasis after orthotopic implantation in nude mice.
A. Bex
,
B. Wullich
,
+4 authors
H. Rübben
Cancer Genetics and Cytogenetics
2001
Corpus ID: 44354310
Highly Cited
1999
Highly Cited
1999
Liarozole Acts Synergistically with 1α,25-Dihydroxyvitamin D3 to Inhibit Growth of DU 145 Human Prostate Cancer Cells by Blocking 24-Hydroxylase Activity.
L. Ly
,
Xiao-yan Zhao
,
L. Holloway
,
D. Feldman
Endocrinology
1999
Corpus ID: 207072917
1α,25-Dihydroxyvitamin D3[ 1,25-(OH)2D3] inhibits the proliferation of many cancer cells in culture, but not the aggressive human…
Expand
Highly Cited
1994
Highly Cited
1994
Inhibition of the activity of ‘basic’ 5α-reductase (type 1) detected in DU 145 cells and expressed in insect cells
S. Délos
,
C. Iehlé
,
P. Martin
,
J. Raynaud
Journal of Steroid Biochemistry and Molecular…
1994
Corpus ID: 21014869
Highly Cited
1994
Highly Cited
1994
Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop.
D. Dondi
,
P. Limonta
,
R. Moretti
,
M. Marelli
,
E. Garattini
,
M. Motta
Cancer Research
1994
Corpus ID: 8960965
The therapeutic options for the treatment of androgen-independent prostatic cancers are rather limited; this is mainly because…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE